APO Research
Talk to an analyst

APO RESEARCH · REPORT

Heart Surgery Perfusion Service

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Heart Surgery Perfusion Service Market Outlook and Growth Opportunities 2026

2 May 2026187 pages

Choose your research edition.

Industry ResearchHeart Surgery Perfusion Service Industry Research Report 2026117 pages · $2,950 USDIndustry Growth & TrendsGlobal Heart Surgery Perfusion Service Industry Growth and Trends Forecast to 203287 pages · $3,450 USDMarket StructureGlobal Heart Surgery Perfusion Service Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032187 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Heart Surgery Perfusion Service Market Outlook and Growth Opportunities 2026187 pages · $4,250 USDMarket Analysis & ForecastGlobal Heart Surgery Perfusion Service Market Analysis and Forecast 2026-2032212 pages · $4,950 USD

Market perspective

The global Heart Surgery Perfusion Service market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Heart Surgery Perfusion Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Heart Surgery Perfusion Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Heart Surgery Perfusion Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Heart Surgery Perfusion Service market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Heart Surgery Perfusion Service market include St George, Comprehensive Care Services, Keystone Perfusion Services, SpecialtyCare, Perfusion Solution, PROCIRCA, Vivacity Perfusion and Cambridge Perfusion Services, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global Heart Surgery Perfusion Service market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Heart Surgery Perfusion Service and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Heart Surgery Perfusion Service revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Heart Surgery Perfusion Service market.

Heart Surgery Perfusion Service Segment by Company

St George

Comprehensive Care Services

Keystone Perfusion Services

SpecialtyCare

Perfusion Solution

PROCIRCA

Vivacity Perfusion

Cambridge Perfusion Services

Heart Surgery Perfusion Service Segment by Type

Cardiopulmonary Bypass (CPB)

Extracorporeal Membrane Oxygenation (ECMO)

Isolated Limb Perfusion

Heart Surgery Perfusion Service Segment by Application

Adult

Children

Heart Surgery Perfusion Service Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Heart Surgery Perfusion Service status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Heart Surgery Perfusion Service key companies, revenue, market share, and recent developments.

3. To split the Heart Surgery Perfusion Service breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Heart Surgery Perfusion Service market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Heart Surgery Perfusion Service significant trends, drivers, influence factors in global and regions.

6. To analyze Heart Surgery Perfusion Service competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Heart Surgery Perfusion Service market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Heart Surgery Perfusion Service and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Heart Surgery Perfusion Service.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Heart Surgery Perfusion Service industry.

Chapter 3: Detailed analysis of Heart Surgery Perfusion Service company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Heart Surgery Perfusion Service in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Heart Surgery Perfusion Service in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Heart Surgery Perfusion Service Industry Trends Table 2. Heart Surgery Perfusion Service Industry Drivers Table 3. Heart Surgery Perfusion Service Industry Opportunities and Challenges Table 4. Heart Surgery Perfusion Service Industry Restraints Table 5. Global Heart Surgery Perfusion Service Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Heart Surgery Perfusion Service Revenue Share by Company (2021-2026) Table 7. Global Heart Surgery Perfusion Service Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Heart Surgery Perfusion Service Key Company Manufacturing Base & Headquarters Table 9. Global Heart Surgery Perfusion Service Company, Product Type & Application Table 10. Global Heart Surgery Perfusion Service Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Heart Surgery Perfusion Service by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Cardiopulmonary Bypass (CPB) Table 15. Significant Companies of Extracorporeal Membrane Oxygenation (ECMO) Table 16. Significant Companies of Isolated Limb Perfusion Table 17. Global Heart Surgery Perfusion Service Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 18. Global Heart Surgery Perfusion Service Sales Value by Type (2021-2026) & (US$ Million) Table 19. Global Heart Surgery Perfusion Service Sales Value by Type (2027-2032) & (US$ Million) Table 20. Global Heart Surgery Perfusion Service Sales Value Share by Type (2021-2026) Table 21. Global Heart Surgery Perfusion Service Sales Value Share by Type (2027-2032) Table 22. Significant Companies of Adult Table 23. Significant Companies of Children Table 24. Global Heart Surgery Perfusion Service Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Heart Surgery Perfusion Service Sales Value by Application (2021-2026) & (US$ Million) Table 26. Global Heart Surgery Perfusion Service Sales Value by Application (2027-2032) & (US$ Million) Table 27. Global Heart Surgery Perfusion Service Sales Value Share by Application (2021-2026) Table 28. Global Heart Surgery Perfusion Service Sales Value Share by Application (2027-2032) Table 29. Global Heart Surgery Perfusion Service Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 30. Global Heart Surgery Perfusion Service Sales Value by Region (2021-2026) & (US$ Million) Table 31. Global Heart Surgery Perfusion Service Sales Value Share by Region (2021-2026) Table 32. Global Heart Surgery Perfusion Service Sales Value by Region (2027-2032) & (US$ Million) Table 33. Global Heart Surgery Perfusion Service Sales Value Share by Region (2027-2032) Table 34. Global Heart Surgery Perfusion Service Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 35. Global Heart Surgery Perfusion Service Sales Value by Country (2021-2026) & (US$ Million) Table 36. Global Heart Surgery Perfusion Service Sales Value Market Share by Country (2021-2026) Table 37. Global Heart Surgery Perfusion Service Sales Value by Country (2027-2032) & (US$ Million) Table 38. Global Heart Surgery Perfusion Service Sales Value Market Share by Country (2027-2032) Table 39. St George Company Information Table 40. St George Business Overview Table 41. St George Heart Surgery Perfusion Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 42. St George Heart Surgery Perfusion Service Product Portfolio Table 43. St George Recent Development Table 44. Comprehensive Care Services Company Information Table 45. Comprehensive Care Services Business Overview Table 46. Comprehensive Care Services Heart Surgery Perfusion Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 47. Comprehensive Care Services Heart Surgery Perfusion Service Product Portfolio Table 48. Comprehensive Care Services Recent Development Table 49. Keystone Perfusion Services Company Information Table 50. Keystone Perfusion Services Business Overview Table 51. Keystone Perfusion Services Heart Surgery Perfusion Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 52. Keystone Perfusion Services Heart Surgery Perfusion Service Product Portfolio Table 53. Keystone Perfusion Services Recent Development Table 54. SpecialtyCare Company Information Table 55. SpecialtyCare Business Overview Table 56. SpecialtyCare Heart Surgery Perfusion Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 57. SpecialtyCare Heart Surgery Perfusion Service Product Portfolio Table 58. SpecialtyCare Recent Development Table 59. Perfusion Solution Company Information Table 60. Perfusion Solution Business Overview Table 61. Perfusion Solution Heart Surgery Perfusion Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 62. Perfusion Solution Heart Surgery Perfusion Service Product Portfolio Table 63. Perfusion Solution Recent Development Table 64. PROCIRCA Company Information Table 65. PROCIRCA Business Overview Table 66. PROCIRCA Heart Surgery Perfusion Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 67. PROCIRCA Heart Surgery Perfusion Service Product Portfolio Table 68. PROCIRCA Recent Development Table 69. Vivacity Perfusion Company Information Table 70. Vivacity Perfusion Business Overview Table 71. Vivacity Perfusion Heart Surgery Perfusion Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 72. Vivacity Perfusion Heart Surgery Perfusion Service Product Portfolio Table 73. Vivacity Perfusion Recent Development Table 74. Cambridge Perfusion Services Company Information Table 75. Cambridge Perfusion Services Business Overview Table 76. Cambridge Perfusion Services Heart Surgery Perfusion Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 77. Cambridge Perfusion Services Heart Surgery Perfusion Service Product Portfolio Table 78. Cambridge Perfusion Services Recent Development Table 79. Research Programs/Design for This Report Table 80. Authors List of This Report Table 81. Secondary Sources Table 82. Primary Sources List of Figures Figure 1. Heart Surgery Perfusion Service Product Image Figure 2. Global Heart Surgery Perfusion Service Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Heart Surgery Perfusion Service Market Size (2021-2032) & (US$ Million) Figure 4. Global Heart Surgery Perfusion Service Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Cardiopulmonary Bypass (CPB) Image Figure 8. Extracorporeal Membrane Oxygenation (ECMO) Image Figure 9. Isolated Limb Perfusion Image Figure 10. Global Heart Surgery Perfusion Service Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 11. Global Heart Surgery Perfusion Service Sales Value Share 2021 VS 2025 VS 2032 Figure 12. Global Heart Surgery Perfusion Service Sales Value Share by Type (2021-2032) Figure 13. Adult Image Figure 14. Children Image Figure 15. Global Heart Surgery Perfusion Service Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 16. Global Heart Surgery Perfusion Service Sales Value Share 2021 VS 2025 VS 2032 Figure 17. Global Heart Surgery Perfusion Service Sales Value Share by Application (2021-2032) Figure 18. Global Heart Surgery Perfusion Service Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 19. Global Heart Surgery Perfusion Service Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 20. North America Heart Surgery Perfusion Service Sales Value (2021-2032) & (US$ Million) Figure 21. North America Heart Surgery Perfusion Service Sales Value Share by Country (%), 2025 VS 2032 Figure 22. Europe Heart Surgery Perfusion Service Sales Value (2021-2032) & (US$ Million) Figure 23. Europe Heart Surgery Perfusion Service Sales Value Share by Country (%), 2025 VS 2032 Figure 24. Asia-Pacific Heart Surgery Perfusion Service Sales Value (2021-2032) & (US$ Million) Figure 25. Asia-Pacific Heart Surgery Perfusion Service Sales Value Share by Country (%), 2025 VS 2032 Figure 26. South America Heart Surgery Perfusion Service Sales Value (2021-2032) & (US$ Million) Figure 27. South America Heart Surgery Perfusion Service Sales Value Share by Country (%), 2025 VS 2032 Figure 28. Middle East & Africa Heart Surgery Perfusion Service Sales Value (2021-2032) & (US$ Million) Figure 29. Middle East & Africa Heart Surgery Perfusion Service Sales Value Share by Country (%), 2025 VS 2032 Figure 30. USA Heart Surgery Perfusion Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 31. USA Heart Surgery Perfusion Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 32. USA Heart Surgery Perfusion Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 33. Canada Heart Surgery Perfusion Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 34. Canada Heart Surgery Perfusion Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 35. Canada Heart Surgery Perfusion Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 36. Mexico Heart Surgery Perfusion Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 37. Mexico Heart Surgery Perfusion Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 38. Mexico Heart Surgery Perfusion Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 39. Germany Heart Surgery Perfusion Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 40. Germany Heart Surgery Perfusion Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 41. Germany Heart Surgery Perfusion Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 42. France Heart Surgery Perfusion Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. France Heart Surgery Perfusion Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. France Heart Surgery Perfusion Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. U.K. Heart Surgery Perfusion Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. U.K. Heart Surgery Perfusion Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. U.K. Heart Surgery Perfusion Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. Italy Heart Surgery Perfusion Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. Italy Heart Surgery Perfusion Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. Italy Heart Surgery Perfusion Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. Spain Heart Surgery Perfusion Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. Spain Heart Surgery Perfusion Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. Spain Heart Surgery Perfusion Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. Russia Heart Surgery Perfusion Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. Russia Heart Surgery Perfusion Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. Russia Heart Surgery Perfusion Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. Netherlands Heart Surgery Perfusion Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. Netherlands Heart Surgery Perfusion Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. Netherlands Heart Surgery Perfusion Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Nordic Countries Heart Surgery Perfusion Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Nordic Countries Heart Surgery Perfusion Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Nordic Countries Heart Surgery Perfusion Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. China Heart Surgery Perfusion Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. China Heart Surgery Perfusion Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. China Heart Surgery Perfusion Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. Japan Heart Surgery Perfusion Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. Japan Heart Surgery Perfusion Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. Japan Heart Surgery Perfusion Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. South Korea Heart Surgery Perfusion Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. South Korea Heart Surgery Perfusion Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. South Korea Heart Surgery Perfusion Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. India Heart Surgery Perfusion Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. India Heart Surgery Perfusion Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. India Heart Surgery Perfusion Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. Australia Heart Surgery Perfusion Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. Australia Heart Surgery Perfusion Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. Australia Heart Surgery Perfusion Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. Southeast Asia Heart Surgery Perfusion Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. Southeast Asia Heart Surgery Perfusion Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. Southeast Asia Heart Surgery Perfusion Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. Brazil Heart Surgery Perfusion Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. Brazil Heart Surgery Perfusion Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. Brazil Heart Surgery Perfusion Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. Argentina Heart Surgery Perfusion Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. Argentina Heart Surgery Perfusion Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. Argentina Heart Surgery Perfusion Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Chile Heart Surgery Perfusion Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Chile Heart Surgery Perfusion Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Chile Heart Surgery Perfusion Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Colombia Heart Surgery Perfusion Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Colombia Heart Surgery Perfusion Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Colombia Heart Surgery Perfusion Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Peru Heart Surgery Perfusion Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Peru Heart Surgery Perfusion Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Peru Heart Surgery Perfusion Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Saudi Arabia Heart Surgery Perfusion Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Saudi Arabia Heart Surgery Perfusion Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Saudi Arabia Heart Surgery Perfusion Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Israel Heart Surgery Perfusion Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Israel Heart Surgery Perfusion Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Israel Heart Surgery Perfusion Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. UAE Heart Surgery Perfusion Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. UAE Heart Surgery Perfusion Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. UAE Heart Surgery Perfusion Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. Turkey Heart Surgery Perfusion Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. Turkey Heart Surgery Perfusion Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. Turkey Heart Surgery Perfusion Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Iran Heart Surgery Perfusion Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Iran Heart Surgery Perfusion Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Iran Heart Surgery Perfusion Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. Egypt Heart Surgery Perfusion Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. Egypt Heart Surgery Perfusion Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. Egypt Heart Surgery Perfusion Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. Years Considered Figure 115. Research Process Figure 116. Key Executives Interviewed

Scope & coverage.

Types
  • Cardiopulmonary Bypass (CPB)
  • Extracorporeal Membrane Oxygenation (ECMO)
  • Isolated Limb Perfusion
Applications
  • Adult
  • Children
Companies covered
  • St George
  • Comprehensive Care Services
  • Keystone Perfusion Services
  • SpecialtyCare
  • Perfusion Solution
  • PROCIRCA
  • Vivacity Perfusion
  • Cambridge Perfusion Services

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Heart Surgery Perfusion Service Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Heart Surgery Perfusion Service Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Heart Surgery Perfusion Service Market Dynamics
  1. 2.1 Heart Surgery Perfusion Service Industry Trends
  2. 2.2 Heart Surgery Perfusion Service Industry Drivers
  3. 2.3 Heart Surgery Perfusion Service Industry Opportunities and Challenges
  4. 2.4 Heart Surgery Perfusion Service Industry Restraints
3 Heart Surgery Perfusion Service Market by Company
  1. 3.1 Global Heart Surgery Perfusion Service Company Revenue Ranking in 2025
  2. 3.2 Global Heart Surgery Perfusion Service Revenue by Company (2021-2026)
  3. 3.3 Global Heart Surgery Perfusion Service Company Ranking (2024-2026)
  4. 3.4 Global Heart Surgery Perfusion Service Company Manufacturing Base and Headquarters
  5. 3.5 Global Heart Surgery Perfusion Service Company Product Type and Application
  6. 3.6 Global Heart Surgery Perfusion Service Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Heart Surgery Perfusion Service Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Heart Surgery Perfusion Service Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Heart Surgery Perfusion Service Market by Type
  1. 4.1 Heart Surgery Perfusion Service Type Introduction
  2. 4.1.1 Cardiopulmonary Bypass (CPB)
  3. 4.1.2 Extracorporeal Membrane Oxygenation (ECMO)
  4. 4.1.3 Isolated Limb Perfusion
  5. 4.2 Global Heart Surgery Perfusion Service Sales Value by Type
  6. 4.2.1 Global Heart Surgery Perfusion Service Sales Value by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Heart Surgery Perfusion Service Sales Value by Type (2021-2032)
  8. 4.2.3 Global Heart Surgery Perfusion Service Sales Value Share by Type (2021-2032)
5 Heart Surgery Perfusion Service Market by Application
  1. 5.1 Heart Surgery Perfusion Service Application Introduction
  2. 5.1.1 Adult
  3. 5.1.2 Children
  4. 5.2 Global Heart Surgery Perfusion Service Sales Value by Application
  5. 5.2.1 Global Heart Surgery Perfusion Service Sales Value by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Heart Surgery Perfusion Service Sales Value by Application (2021-2032)
  7. 5.2.3 Global Heart Surgery Perfusion Service Sales Value Share by Application (2021-2032)
6 Heart Surgery Perfusion Service Regional Value Analysis
  1. 6.1 Global Heart Surgery Perfusion Service Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Heart Surgery Perfusion Service Sales Value by Region (2021-2032)
  3. 6.2.1 Global Heart Surgery Perfusion Service Sales Value by Region: 2021-2026
  4. 6.2.2 Global Heart Surgery Perfusion Service Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Heart Surgery Perfusion Service Sales Value (2021-2032)
  7. 6.3.2 North America Heart Surgery Perfusion Service Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Heart Surgery Perfusion Service Sales Value (2021-2032)
  10. 6.4.2 Europe Heart Surgery Perfusion Service Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Heart Surgery Perfusion Service Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Heart Surgery Perfusion Service Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Heart Surgery Perfusion Service Sales Value (2021-2032)
  16. 6.6.2 South America Heart Surgery Perfusion Service Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Heart Surgery Perfusion Service Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Heart Surgery Perfusion Service Sales Value Share by Country, 2025 VS 2032
7 Heart Surgery Perfusion Service Country-level Value Analysis
  1. 7.1 Global Heart Surgery Perfusion Service Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Heart Surgery Perfusion Service Sales Value by Country (2021-2032)
  3. 7.2.1 Global Heart Surgery Perfusion Service Sales Value by Country (2021-2026)
  4. 7.2.2 Global Heart Surgery Perfusion Service Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Heart Surgery Perfusion Service Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Heart Surgery Perfusion Service Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Heart Surgery Perfusion Service Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Heart Surgery Perfusion Service Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Heart Surgery Perfusion Service Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Heart Surgery Perfusion Service Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Heart Surgery Perfusion Service Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Heart Surgery Perfusion Service Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Heart Surgery Perfusion Service Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Heart Surgery Perfusion Service Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Heart Surgery Perfusion Service Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Heart Surgery Perfusion Service Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Heart Surgery Perfusion Service Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Heart Surgery Perfusion Service Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Heart Surgery Perfusion Service Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Heart Surgery Perfusion Service Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Heart Surgery Perfusion Service Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Heart Surgery Perfusion Service Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Heart Surgery Perfusion Service Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Heart Surgery Perfusion Service Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Heart Surgery Perfusion Service Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Heart Surgery Perfusion Service Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Heart Surgery Perfusion Service Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Heart Surgery Perfusion Service Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Heart Surgery Perfusion Service Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Heart Surgery Perfusion Service Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Heart Surgery Perfusion Service Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Heart Surgery Perfusion Service Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Heart Surgery Perfusion Service Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Heart Surgery Perfusion Service Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Heart Surgery Perfusion Service Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Heart Surgery Perfusion Service Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Heart Surgery Perfusion Service Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Heart Surgery Perfusion Service Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Heart Surgery Perfusion Service Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Heart Surgery Perfusion Service Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Heart Surgery Perfusion Service Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Heart Surgery Perfusion Service Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Heart Surgery Perfusion Service Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Heart Surgery Perfusion Service Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Heart Surgery Perfusion Service Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Heart Surgery Perfusion Service Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Heart Surgery Perfusion Service Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Heart Surgery Perfusion Service Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Heart Surgery Perfusion Service Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Heart Surgery Perfusion Service Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Heart Surgery Perfusion Service Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Heart Surgery Perfusion Service Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Heart Surgery Perfusion Service Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Heart Surgery Perfusion Service Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Heart Surgery Perfusion Service Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Heart Surgery Perfusion Service Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Heart Surgery Perfusion Service Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Heart Surgery Perfusion Service Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Heart Surgery Perfusion Service Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Heart Surgery Perfusion Service Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Heart Surgery Perfusion Service Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Heart Surgery Perfusion Service Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Heart Surgery Perfusion Service Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Heart Surgery Perfusion Service Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Heart Surgery Perfusion Service Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Heart Surgery Perfusion Service Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Heart Surgery Perfusion Service Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Heart Surgery Perfusion Service Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Heart Surgery Perfusion Service Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Heart Surgery Perfusion Service Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Heart Surgery Perfusion Service Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Heart Surgery Perfusion Service Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Heart Surgery Perfusion Service Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Heart Surgery Perfusion Service Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Heart Surgery Perfusion Service Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Heart Surgery Perfusion Service Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Heart Surgery Perfusion Service Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Heart Surgery Perfusion Service Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Heart Surgery Perfusion Service Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Heart Surgery Perfusion Service Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Heart Surgery Perfusion Service Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Heart Surgery Perfusion Service Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Heart Surgery Perfusion Service Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Heart Surgery Perfusion Service Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Heart Surgery Perfusion Service Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Heart Surgery Perfusion Service Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Heart Surgery Perfusion Service Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Heart Surgery Perfusion Service Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 St George
  2. 8.1.1 St George Company Information
  3. 8.1.2 St George Business Overview
  4. 8.1.3 St George Heart Surgery Perfusion Service Revenue and Gross Margin (2021-2026)
  5. 8.1.4 St George Heart Surgery Perfusion Service Product Portfolio
  6. 8.1.5 St George Recent Developments
  7. 8.2 Comprehensive Care Services
  8. 8.2.1 Comprehensive Care Services Company Information
  9. 8.2.2 Comprehensive Care Services Business Overview
  10. 8.2.3 Comprehensive Care Services Heart Surgery Perfusion Service Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Comprehensive Care Services Heart Surgery Perfusion Service Product Portfolio
  12. 8.2.5 Comprehensive Care Services Recent Developments
  13. 8.3 Keystone Perfusion Services
  14. 8.3.1 Keystone Perfusion Services Company Information
  15. 8.3.2 Keystone Perfusion Services Business Overview
  16. 8.3.3 Keystone Perfusion Services Heart Surgery Perfusion Service Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Keystone Perfusion Services Heart Surgery Perfusion Service Product Portfolio
  18. 8.3.5 Keystone Perfusion Services Recent Developments
  19. 8.4 SpecialtyCare
  20. 8.4.1 SpecialtyCare Company Information
  21. 8.4.2 SpecialtyCare Business Overview
  22. 8.4.3 SpecialtyCare Heart Surgery Perfusion Service Revenue and Gross Margin (2021-2026)
  23. 8.4.4 SpecialtyCare Heart Surgery Perfusion Service Product Portfolio
  24. 8.4.5 SpecialtyCare Recent Developments
  25. 8.5 Perfusion Solution
  26. 8.5.1 Perfusion Solution Company Information
  27. 8.5.2 Perfusion Solution Business Overview
  28. 8.5.3 Perfusion Solution Heart Surgery Perfusion Service Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Perfusion Solution Heart Surgery Perfusion Service Product Portfolio
  30. 8.5.5 Perfusion Solution Recent Developments
  31. 8.6 PROCIRCA
  32. 8.6.1 PROCIRCA Company Information
  33. 8.6.2 PROCIRCA Business Overview
  34. 8.6.3 PROCIRCA Heart Surgery Perfusion Service Revenue and Gross Margin (2021-2026)
  35. 8.6.4 PROCIRCA Heart Surgery Perfusion Service Product Portfolio
  36. 8.6.5 PROCIRCA Recent Developments
  37. 8.7 Vivacity Perfusion
  38. 8.7.1 Vivacity Perfusion Company Information
  39. 8.7.2 Vivacity Perfusion Business Overview
  40. 8.7.3 Vivacity Perfusion Heart Surgery Perfusion Service Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Vivacity Perfusion Heart Surgery Perfusion Service Product Portfolio
  42. 8.7.5 Vivacity Perfusion Recent Developments
  43. 8.8 Cambridge Perfusion Services
  44. 8.8.1 Cambridge Perfusion Services Company Information
  45. 8.8.2 Cambridge Perfusion Services Business Overview
  46. 8.8.3 Cambridge Perfusion Services Heart Surgery Perfusion Service Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Cambridge Perfusion Services Heart Surgery Perfusion Service Product Portfolio
  48. 8.8.5 Cambridge Perfusion Services Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst